Menstrual products: culprits or bystanders in endometriosis and adenomyosis pathogenesis?

Products that may reduce menstrual flow from the endometrial cavity to the vagina (i.e. tampons and menstrual cups) could facilitate retrograde menstruation and the spillage of blood into the myometrium, two mechanisms which could be major determinants in endometriosis and adenomyosis pathogenesis. The aim of this narrative review is to summarize the evidence regarding the mechanical role menstrual products may have in the pathogenesis of these two conditions. Evidence in this regard is inconclusive. While Darrow and colleagues observed that 14 or more years of tampon use were associated with endometriosis (OR 3.6; 95% CI, 1.04–13.5); in Meaddough and colleagues’ retrospective study, the percentage of women using pads only was significantly higher among those with endometriosis than among those without the condition (31% vs 22%). Three further groups failed to find an association between endometriosis/adenomyosis and any type of menstrual product. The only case that may be considered as a sort of proof-of-concept of the association between products potentially reducing anterograde menstrual flow and endometriosis was reported by Spechler and colleagues, who described the case of a 41 year-old who developed endometriosis after having used a menstrual cup on a regular basis. However, the number of studies on the subject is scarce, study populations are exiguous and a greater attention to temporality of endometriosis onset in relation to when women started habitually using a specific menstrual product is needed. Confounding variables including type and quantity of endocrine disruptors contained in menstrual products should also be addressed. At the present moment, no recommendation can be provided on the safety of one type of menstrual product compared to another. Similar content being viewed by others

Punzi MC, Werner M (2020) Challenging the menstruation taboo one sale at a time: the role of social entrepreneurs in the period revolution. In: Bobel C, Winkler IT, Fahs B, Hasson KA, Kissling EA, Roberts TA (eds) The palgrave handbook of critical menstruation studies. Palgrave Macmillan, Singapore Werner MD, Punzi MC, Turkenburg AJK (2023) Period power: organizational stigma, multimodality, and social entrepreneurship in the menstrual products industry. J Manag Stud. https://doi.org/10.1111/joms.12974 Upson K, Shearston JA, Kioumourtzoglou MA (2022) An epidemiologic review of menstrual blood loss as an excretion route for per- and polyfluoroalkyl substances. Curr Environ Health Rep 9(1):29–37. https://doi.org/10.1007/s40572-022-00332-0 Fortune Business Insights (2023) The global feminine hygiene products market is anticipated to grow from $41.29 billion in 2023 to $62.66 billion by 2030, at a CAGR of 6.1%. Report No.: FBI103530. pp. 160. Available at: https://www.fortunebusinessinsights.com/feminine-hygiene-products-market-103530 Zota AR, Franklin ET, Weaver EB, Shamasunder B, Williams A, Siegel EL, Dodson RE (2023) Examining differences in menstrual and intimate care product use by race/ethnicity and education among menstruating individuals. Front Reprod Health 6(5):1286920. https://doi.org/10.3389/frph.2023.1286920 Blair L, Bajón-Fernández Y, Villa R (2022) An exploratory study of the impact and potential of menstrual hygiene management waste in the UK. Clean Eng Technol 7:100435 Masuda H, Schwab KE, Filby CE, Tan CSC, Tsaltas J, Weston GC, Gargett CE (2021) Endometrial stem/progenitor cells in menstrual blood and peritoneal fluid of women with and without endometriosis. Reprod Biomed Online 43(1):3–13. https://doi.org/10.1016/j.rbmo.2021.04.008 Vinatier D, Cosson M, Dufour P (2000) Is endometriosis an endometrial disease? Eur J Obstetr Gynecol Reprod Biol. https://doi.org/10.1016/S0301-2115(99)00263-8 Attia GR et al (2000) Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab 85:2897 Spechler S, Nieman LK, Premkumar A, Stratton P (2003) The keeper, a menstrual collection device, as a potential cause of endometriosis and adenomyosis. Gynecol Obstet Invest 56(1):35–37. https://doi.org/10.1159/000072329 Scialli AR (2001) Tampons, dioxins, and endome- triosis. Reprod Toxicol 15:231–238 Archer JC, Mabry-Smith R, Shojaee S, Threet J, Eckert JJ, Litman VE (2005) Dioxin and furan levels found in tampons. J Womens Health (Larchmt) 14:311–315 Hennegan J, Winkler IT, Bobel C, Keiser D, Hampton J, Larsson G et al (2021) Menstrual health: a definition for policy, practice, and research. Sex Reprod Health Matters 29(1):1–8 Sommer M, Sahin M (2013) Overcoming the taboo: advancing the global agenda for menstrual hygiene management for schoolgirls. Am J Public Health 103(9):1556–1559 Mahajan T (2019) Imperfect information in menstrual health and the role of informed choice. Indian J Gender Stud 26:59–78 Marroquin J, Kiomourtzoglou MA, Scranton A, Pollack AZ (2023) Chemicals in menstrual products: a systematic review. BJOG. https://doi.org/10.1111/1471-0528.17668 Srikrishna S, Cardozo L (2013) The vagina as a route for drug delivery: a review. Int Urogynecol J 24(4):537–543 Darrow SL, Vena JE, Batt RE, Zielezny MA, Michalek AM, Selman S (1993) Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 4(2):135–142. https://doi.org/10.1097/00001648-199303000-00009 Meaddough EL, Olive DL, Gallup P, Perlin M, Kliman HJ (2002) Sexual activity, orgasm and tampon use are associated with a decreased risk for endometriosis. Gynecol Obstet Invest 53(3):163–169. https://doi.org/10.1159/000058368 Ballweg ML, Quinn BW (2002) Concerning the article by Meaddough et al: sexual activity, orgasm and tampon use are associated with a decreased risk for endometriosis. Gynecol Obstet Invest 54(2):63. https://doi.org/10.1159/000068355 Cramer DW, Wilson E, Stillman RJ, Berger MJ, Belisle S, Schiff I, Albrecht B, Gibson M, Stadel BV, Schoenbaum SC (1986) The relation of endometriosis to menstrual characteristics, smoking, and exercise. JAMA 255(14):1904–1908 Heilier JF, Donnez J, Verougstraete V, Donnez O, Grandjean F, Haufroid V, Nackers F, Lison D (2006) Cadmium, lead and endometriosis. Int Arch Occup Environ Health 80(2):149–153. https://doi.org/10.1007/s00420-006-0114-7 Treloar SA, Bell TA, Nagle CM, Purdie DM, Green AC (2010) Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gynecol 202(6):534. https://doi.org/10.1016/j.ajog.2009.10.857 Branch F, Woodruff TJ, Mitro SD, Zota AR (2015) Vaginal douching and racial/ethnic disparities in phthalates exposures among reproductive-aged women: national health and nutrition examination survey 2001–2004. Environ Health 15(14):57. https://doi.org/10.1186/s12940-015-0043-6 Trisha M, Inga TW (2020) The palgrave handbook of critical menstruation studies. In: Bobel C, Winkler IT, Fahs B (eds) Chapter 15 transnational engagements cultural and religious practices related to menstruation. Palgrave Macmillan, Singapore Fourcassier S, Douziech M, Pérez-López P, Schiebinger L (2022) Menstrual products: a comparable life cycle assessment. Clean Environ Syst 7:100096. https://doi.org/10.1016/j.cesys.2022.100096 Tamiru A, Tsegay G, Wubie M, Gedefaw M, Tomczyk S, Tekola-Ayele F (2014) Podoconiosis patients’ willingness to pay for treatment services in northwest Ethiopia: potential for cost recovery. BMC Public Health 19(14):259. https://doi.org/10.1186/1471-2458-14-259 Boyers M, Garikipati S, Biggane A, Douglas E, Hawkes N, Kiely C, Giddings C, Kelly J, Exley D, Phillips-Howard PA, Mason L (2022) Period poverty: the perceptions and experiences of impoverished women living in an inner-city area of northwest England. PLoS ONE 17(7):e0269341. https://doi.org/10.1371/journal.pone.0269341 Palovick KA, Hunter E, Teni MT, Sebert KA (2024) Period product insecurity is increasing in the United States: trends from 2018 to 2021. J Womens Health (Larchmt) 33(1):20–27. https://doi.org/10.1089/jwh.2023.0367 Hamlaci Baskaya Y, Unlu Bidik N, Yolcu B (2024) The effect of level of anxiety about climate change on the use of feminine hygiene products. Int J Gynaecol Obstet. https://doi.org/10.1002/ijgo.15324 Ramsay C, Hennegan J, Douglass CH, Eddy S, Head A, Lim MSC (2023) Reusable period products: use and perceptions among young people in Victoria, Australia. BMC Womens Health 23(1):102. https://doi.org/10.1186/s12905-023-02197-3 Medina-Perucha L, López-Jiménez T, Holst AS, Jacques-Aviñó C, Munrós- Feliu J, Martínez-Bueno C et al (2022) Use and perceptions on reusable and non-reusable menstrual products in Spain: a mixed-methods study. PLoS ONE 17(3):e0265646 Vercellini P, Salmeri N, Somigliana E, Piccini M, Caprara F, Viganò P, De Matteis S (2024) Müllerian anomalies and endometriosis as potential explanatory models for the retrograde menstruation/implantation and the embryonic remnants/celomic metaplasia pathogenic theories: a systematic review and meta-analysis. Hum Reprod. https://doi.org/10.1093/humrep/deae086 Marsh EE, Laufer MR (2005) Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly. Fertil Steril 83(3):758–760. https://doi.org/10.1016/j.fertnstert.2004.08.025 Matsuura K, Ohtake H, Katabuchi H, Okamura H (1999) Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest 47(1):18–20. https://doi.org/10.1159/000052855 Taylor HS, Kotlyar AM, Flores VA (2021) Endometriosis is a chronic systemic disease: clinical challenges and novel innovations. Lancet 397(10276):839–852. https://doi.org/10.1016/S0140-6736(21)00389-5 Horne AW, Missmer SA (2022) Pathophysiology, diagnosis, and management of endometriosis. BMJ 14(379):e070750. https://doi.org/10.1136/bmj-2022-070750 Yuan W, Wu Y, Chai X, Wu X (2022) The colonized microbiota composition in the peritoneal fluid in women with endometriosis. Arch Gynecol Obstet 305(6):1573–1580. https://doi.org/10.1007/s00404-021-06338-7 Iavazzo C, Vrachnis N, Gkegkes ID (2023) Peritoneal bacteria contamination and endometriosis pathogenesis. Arch Gynecol Obstet 307(1):221–222. https://doi.org/10.1007/s00404-022-06467-7 DeVito MJ, Schecter A (2002) Exposure assessment to dioxins from the use of tampons and diapers. Environ Health Perspect 110(1):23–28. https://doi.org/10.1289/ehp.0211023 Genet R (2018) OPINION of the French agency for food, environmental and occupational health & safety on the safety of feminine hygiene products. Paris: The French Agency for Food, Environmental and Occupational Health & Safety (2018). Available at: https://www.anses.fr/en/system/files/CONSO2016SA0108EN.pdf Ishii S, Katagiri R, Kataoka T, Wada M, Imai S, Yamasaki K (2014) Risk assessment study of dioxins in sanitary napkins produced in Japan. Regul Toxicol Pharmacol 70(1):357–362. https://doi.org/10.1016/j.yrtph.2014.07.020 Gregory S (2014) Termékteszt: tamponok és egészségügyi betétek. Budapest: Tudatos Vásárlók (2014). Available at: https://tudatosvasarlo.hu/termekteszt-tamponok-es-egeszsegugyi-betetek-0/. Accessed on 30 Aug 2023 Gao CJ, Wang F, Shen HM, Kannan K, Guo Y (2020) Feminine hygiene products–a neglected source of phthalate exposure in women. Environ Sci Technol 54(2):930–937. https://doi.org/10.1021/acs.est.9b03927 Kuki Á, Zelei G, Nagy L, Nagy T, Zsuga M, Kéki S (2019) Rapid mapping of various chemicals in personal care and healthcare products by direct analysis in real time mass spectrometry. Talanta 192:241–247. https://doi.org/10.1016/j.talanta.2018.09.054 Scranton A (2013) Chem fatale: potential health effects of toxic chemicals in feminine care products. Missoula, MT: Women’s Voices for the Earth. pp. 23. Available at: https://womensvoices.org/menstrual-care-products/chem-fatale-report/ #:∼:text=Tampons%20Hazardous%20ingredients%20may%20include,endocrine% 20disruption%2C%20and%20allergic%20rash Kim M, Park HJ, Bae ON, Baek SH (2020) Development and uncertainty estimation of cryogenic homogenization and static headspace–gas chromatography–mass spectrometry method for the simultaneous determination of twelve toxic volatiles in disposable menstrual products. Microchem J 158:105291. https://doi.org/10.1016/j.microc.2020.105291 Liao C, Kannan K (2014) A survey of alkylphenols, bisphenols, and triclosan in personal care products from China and the United States. Arch Environ Contam Toxicol 67(1):50–59. https://doi.org/10.1007/s00244-014-0016-8 Chow WH, Daling JR, Weiss NS, Moore DE, Soderstrom R (1985) Vaginal douching as a potential risk factor for tubal ectopic pregnancy. Am J Obstet Gynecol 153(7):727–729. https://doi.org/10.1016/0002-9378(85)90332-1 Zhang J, Thomas AG, Leybovich E (1997) Vaginal douching and adverse health effects: a meta-analysis. Am J Public Health 87(7):1207–1211. https://doi.org/10.2105/AJPH.87.7.1207 Klebanoff MA, Nansel TR, Brotman RM, Zhang J, Yu KF, Schwebke JR et al (2010) Personal hygienic behaviors and bacterial vaginosis. Sex Transm Dis 37(2):94. https://doi.org/10.1097/OLQ.0b013e3181bc063c Tang Z, Chai M, Cheng J, Wang Y, Huang Q (2019) Occurrence and distribution of phthalates in sanitary napkins from six countries: implications for women’s health. Environ Sci Technol 53(23):13919–13928. https://doi.org/10.1021/acs.est.9b03838 Park CJ, Barakat R, Ulanov A, Li Z, Lin PC, Chiu K et al (2019) Sanitary pads and diapers contain higher phthalate contents than those in common commercial plastic products. Reprod Toxicol 84:114–121. https://doi.org/10.1016/j.reprotox.2019.01.005 Rashidi BH, Amanlou M, Lak TB, Ghazizadeh M, Eslami B (2017) A case-control study of bisphenol A and endometrioma among subgroup of Iranian women. J Res Med Sci 27(22):7. https://doi.org/10.4103/1735-1995.199086 Lin N, Ding N, Meza-Wilson E, Devasurendra AM, Godwin C, Park SK et al (2020) Volatile organic compounds in feminine hygiene products sold in the US market: a survey of products and health risks. Environ Int 144:105740. https://doi.org/10.1016/j.envint.2020.105740 Marcelis Q, Gatzios A, Deconinck E, Rogiers V, Vanhaecke T, Desmedt B (2021) Development and application of a novel method to assess exposure levels of sensitizing and irritating substances leaching from menstrual hygiene products. Emerg Contam 7:116–123. https://doi.org/10.1016/j.emcon.2021.02.004 Andrea D (2018) Is there pesticide residue on your tampons? Our independent testing gets specific | naturally savvy. NaturallySavvy.com (2018). Available at: https:// naturallysavvy.com/care/is-there-pesticide-residue-on-your-tampons-our- independent-testing-gets-specific/. Accessed on 30 Aug 2023 Singh J, Mumford SL, Pollack AZ, Schisterman EF, Weisskopf MG, Navas-Acien A et al (2019) Tampon use, environmental chemicals and oxidative stress in the BioCycle study. Environ Health 18(1):11. https://doi.org/10.1186/s12940-019-0452-z Desmedt B, Marcelis Q, Zhilivoda D, Deconinck E (2020) Sensitizing fragrances in absorbent hygiene products. Contact Dermatitis 82(5):279–282. https://doi.org/10.1111/cod.13472 Heilier JF, Donnez J, Defrere S, Van Kerckhove V, Donnez O, Lison D (2006) Serum dioxin-like compounds and aromatase (CYP19) expression in endometriotic tissues. Toxicol Lett 167(3):238–244. https://doi.org/10.1016/j.toxlet.2006.10.005 Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T et al (1997) Expression of aromatase cytochrome P450 protein and mes- senger ribonucleic acid in human endometriotic and adenomyotic tis- sues but not in normal endometrium. Biol Reprod 57:514–519 Hahn ME (2003) Evolutionary and physiological perspectives on Ah receptor function and dioxin toxicity. In: Schecter A, Gasiewicz TA (eds) Dioxins and health, 2nd edn. Wiley-Interscience, Hoboken, pp 559–602 Mimura J, Fujii-Kuriyama Y (2003) Functional role of AhR in the expression of toxic effects by TCDD. Biochim Biophys Acta 1619:263–268 Monnin N, Fattet AJ, Koscinski I (2023) Endometriosis: update of pathophysiology, (Epi) genetic and environmental involvement. Biomedicines 11(3):978. https://doi.org/10.3390/biomedicines11030978 Reinsberg J, Wegener-Toper P, van der Ven K, van der Ven H, Klingmueller D (2009) Effect of mono-(2-ethylhexyl) phthalate on steroid production of human granulosa cells. Toxicol Appl Pharmacol 239(1):116–123. https://doi.org/10.1016/j.taap.2009.05.022 Davis BJ, Maronpot RR, Heindel JJ (1994) Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicol Appl Pharmacol 128(2):216–223. https://doi.org/10.1006/taap.1994.1200 Gupta RK, Singh JM, Leslie TC, Meachum S, Flaws JA, Yao HH (2010) Di-(2-ethylhexyl) phthalate and mono-(2-ethylhexyl) phthalate inhibit growth and reduce estradiol levels of antral follicles in vitro. Toxicol Appl Pharmacol 242(2):224–230. https://doi.org/10.1016/j.taap.2009.10.011 Patel LG, Warrington SJ, Pearson RM (1983) Propranolol concentrations in plasma after insertion into the vagina. Br Med J (Clin Res Ed) 287(6401):1247–1248. https://doi.org/10.1136/bmj.287.6401.1247 Farage MA, Meyer S, Walter D (2004) Evaluation of modifications of the traditional patch test in assessing the chemical irritation potential of feminine hygiene products. Skin Res Technol 10(2):73–84. https://doi.org/10.1111/j.1600-0846.2004.00054.x Hussain A, Ahsan F (2005) The vagina as a route for systemic drug delivery. J Control Release 103(2):301–313. https://doi.org/10.1016/j.jconrel.2004.11.034 Katz TA, Yang Q, Treviño LS, Walker CL, Al-Hendy A (2016) Endocrine-disrupting chemicals and uterine fibroids. Fertil Steril 106(4):967–977 Smarr MM, Kannan K, Louis GMB (2016) Endocrine disrupting chemicals and endometriosis. Fertil Steril 106(4):959–966 Stephens VR, Rumph JT, Ameli S, Bruner-Tran KL, Osteen KG (2022) The potential relationship between environmental endocrine disruptor exposure and the development of endometriosis and adenomyosis. Front Physiol 12:807685. https://doi.org/10.3389/fphys.2021.807685 Dutta S, Banu SK, Arosh JA (2023) Endocrine disruptors and endometriosis. Reprod Toxicol 115:56–73. https://doi.org/10.1016/j.reprotox.2022.11.007 Funding None. Author information Authors and Affiliations Contributions All authors contributed to the literature review for the manuscript. The first draft of the manuscript was written by G.E.C. All authors edited and commented on previous versions of the manuscript. All authors read and approved the final manuscript. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published. Corresponding author Ethics declarations Conflict of interest None. Ethical approval Not applicable. Informed consent Not applicable. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Cetera, G.E., Punzi, M.C., Merli, C.E.M. et al. Menstrual products: culprits or bystanders in endometriosis and adenomyosis pathogenesis?. Arch Gynecol Obstet 310, 1823–1829 (2024). https://doi.org/10.1007/s00404-024-07713-w Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00404-024-07713-w